27.01.2020
- Sanofi has completed its acquisition of US biotech Synthorx as planned for $68 per share in cash. This follows expiration of the French pharma giant’s tender offer for all of the...
12.12.2019
- The race among international pharmaceutical producers to beef up their oncology portfolio is heating up. In one of the latest deals, US Merck has signed a definitive agreement to...
10.12.2019
- French drugmaker Sanofi has signed a definitive agreement to buy Synthorx, a US clinical-stage US biotech focused on cancer and autoimmune disorders, for $68 per share. The cash...
21.11.2019
- Eli Lilly is investing $400 million at its Lilly Technology Center campus in Indianapolis, Indiana, USA, to expand capacity for its growing portfolio of diabetes medicines and...
07.11.2019
- French drugmaker Sanofi has paid $315 million to investors to settle claims it dragged its feet on advancing the development of multiple sclerosis drug Lemtrada, which it acquired...
26.09.2019
- German drug discovery and development company Evotec has entered into a strategic, multi-year collaboration with Japan’s Takeda Pharmaceutical that could be worth in excess of $850...
19.09.2019
- French drugmaker Sanofi and US pharma and medical devices company Abbott Laboratories have teamed up to integrate glucose sensing and insulin delivery technologies, with the aim of...
09.09.2019
- The Together for Sustainability (TFS) initiative was launched in 2011 as a joint program of chemical companies for sustainable supply chains. Its goal is to develop and implement a...
05.09.2019
- The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021. One important driver is the trend towards outsourcing of development and manu...
25.07.2019
- Under an exclusive deal with Roche, French drugmaker Sanofi has secured non-prescription rights to the Swiss pharmaceutical giant’s now off-patent influenza drug Tamiflu in the US...
